Pravin R. Chaturvedi

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Chaturvedi Pravin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pravin R. Chaturvedi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Jaguar Health, Inc. Chief Scientific Officer Convertible Promissory Note 3,785 $75,700,000 $20000.00 24 Jun 2025 Direct
Jaguar Health, Inc. Chief Scientific Officer Common Stock 11,938 $20,294 $1.70 11 Dec 2025 Direct
Jaguar Health, Inc. Chief Scientific Officer Stock Option (right to buy) 11,740 11 Dec 2025 Direct
Jaguar Health, Inc. Chief Scientific Officer Warrant to Purchase Common Stock 3,600 24 Jun 2025 Direct

Insider Reports Filed by Pravin R. Chaturvedi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JAGX Jaguar Health, Inc. 11 Dec 2025 2 $0 4 Chief Scientific Officer 15 Dec 2025, 18:02
JAGX Jaguar Health, Inc. 24 Jun 2025 3 +$3,700,000 4 Chief Scientific Officer 26 Jun 2025, 16:34
JAGX Jaguar Health, Inc. 31 Mar 2025 2 +$72,000,000 4 Chief Scientific Officer 02 Apr 2025, 20:10
JAGX Jaguar Health, Inc. 08 Oct 2024 2 $0 4 Chief Scientific Officer 10 Oct 2024, 21:57
JAGX Jaguar Health, Inc. 17 May 2024 2 $0 4 Chief Scientific Officer 21 May 2024, 17:04
JAGX Jaguar Health, Inc. 05 Apr 2024 2 $0 4 Chief Scientific Officer 17 Apr 2024, 16:33
JAGX Jaguar Health, Inc. 14 Aug 2023 1 $0 4 Chief Scientific Officer 14 Aug 2023, 16:50
JAGX Jaguar Health, Inc. 17 May 2023 2 $0 4 Chief Scientific Officer 19 May 2023, 21:42
JAGX Jaguar Health, Inc. 05 Apr 2023 2 $0 4/A Chief Scientific Officer 19 May 2023, 21:41
JAGX Jaguar Health, Inc. 27 Dec 2022 1 $0 4 Chief Scientific Officer 28 Dec 2022, 20:18
JAGX Jaguar Health, Inc. 05 Apr 2022 2 $0 4/A Chief Scientific Officer 19 May 2023, 20:44
JAGX Jaguar Health, Inc. 28 Mar 2022 1 $0 4 Chief Scientific Officer 30 Mar 2022, 21:34
JAGX Jaguar Health, Inc. 01 Mar 2022 0 $0 3 Chief Scientific Officer 29 Mar 2022, 16:30